Warthausen, Germany

Barbara Enenkel

This inventor holds 20 USPTO granted patents and 11 published patent applications, plus 7 CIPO patents and 8 EPO patents, primarily in Biotechnology Innovation. Top assignees: Boehringer Ingelheim Pharma Gmbh & Co Kg, Boehringer Ingelheim International Gmbh, Boehringer Ingelheim Pharma Kg. Active years: 2000-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Barbara Enenkel. Retrieved from https://idiyas.com/inventor/barbara-enenkel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 

% Patents Active = 100.0


 

Average Co-Inventor Count = 1.8

ph-index = 4

Forward Citations = 67(Granted Patents)


Company Filing History:


Years Active: 2000-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Anti-PSGL-1 Antibodies
Regulatory Nucleic Acids
Artificial Introns
Heterologous Intron
Protein Production
CHO Cells
Recombination Sequences
Neomycin-Phosphotransferase
Eukaryotic Cells
Expression Vectors
Homologous Promoters
20 patents (USPTO):Explore Patents

Title: The Innovative Work of Barbara Enenkel: Pioneering Inventor from Warthausen

Introduction:

Barbara Enenkel, a highly accomplished inventor hailing from Warthausen, Germany, has made significant contributions to the field of biotechnology with her groundbreaking patents and research endeavors.

Latest Patents:

Among her impressive portfolio of 20 patents, Barbara Enenkel's recent inventions include "Anti-PSGL-1 antibodies and uses thereof." These antibodies are designed to immunospecifically bind to PSGL-1, offering promising applications in treating disorders associated with activated T cells. Additionally, her work on regulatory nucleic acid elements showcases her expertise in enhancing gene expression, particularly in eukaryotic genomes like CHO-DG44.

Career Highlights:

Barbara Enenkel has notably lent her expertise to renowned companies such as Boehringer Ingelheim Pharma GmbH & Co. KG and Boehringer Ingelheim International GmbH. Her invaluable contributions have played a pivotal role in advancing cutting-edge biopharmaceutical technologies within these esteemed organizations.

Collaborations:

Throughout her career, Barbara Enenkel has collaborated with esteemed professionals in the field, including distinguished coworkers like Juergen Fieder and Ralf Otto. Together, they have synergistically worked towards pioneering solutions that have propelled the boundaries of biotechnological innovation.

Conclusion:

Barbara Enenkel's exceptional work as an inventor and researcher underscores her unwavering dedication to pushing the envelope of biotechnological advancements. With a remarkable track record of patents and collaborations, she stands as a testament to the transformative power of innovation and ingenuity in shaping the future of biopharmaceutical sciences.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…